Thanks for the reply, I appreciate the info.
Not sure about the 'heavily weighted' H2 bit. I can see on page 6 of the FY 15 results presentation that it says EBITDA will be weighted to H2. Does it say 'heavily' somewhere ?
In FY15 the H1/H2 split was 48/52 so not sure why it would be much bigger than that this year. SGS business is mostly RTA, which you would think occur evenly throughout the year, so not much of a H1/H2 split. Is there further info on the guidance anywhere ?
- Forums
- ASX - By Stock
- SGH
- H1FY16 EBITDAW Figure
H1FY16 EBITDAW Figure, page-3
Featured News
Add SGH (ASX) to my watchlist
(20min delay)
|
|||||
Last
54.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $84.26M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
SGH (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online